Hazardous giant pharyngoesophageal liposarcoma
- Subagar Anbarasan ,
- Suresh Mani ,
- Gaurav Goel and
- Amit Singh Chirom
- Department of ENT - Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
- Correspondence to Dr Suresh Mani; msuresh.doc@gmail.com
Abstract
A man in his early 80s presented to the otorhinolaryngology department with progressively worsening dysphagia to solids and a recent episode of difficulty breathing accompanied by a very brief expulsion of a solid mass from the mouth. Based on the endoscopic appearance of a fatty lesion of an elongated mass with a thick stalk on the posterior pharyngeal wall, a diagnosis of the benign fibrovascular polyp was given after clinical and radiological correlation. The pharyngeal polyp was resected at the base of its pedicle by transoral endoscopy with a thunder beat vessel sealing device. Histopathological examination of the mass revealed a well-differentiated liposarcoma composed of mature adipocytes. Following surgical excision, the patient made a full recovery. This case signifies the integrated role of preoperative biopsy, new surgical technologies and targeted therapies in managing pharyngoesophageal polyps.
Background
Benign fibrovascular polyps (FVP) of the upper aerodigestive tract are uncommon and most commonly occur in the oesophagus, with only a few cases occurring in the hypopharynx. Malignant transformation of these polyps is extremely rare. A rare liposarcoma that mimics a benign polyp occasionally occurs in the hypopharynx. Only 40 cases of hypopharyngeal liposarcoma have been documented in the literature. Because the clinical and radiological features are almost identical to the benign counterpart, diagnosing the lesion during the preoperative period is difficult.1–3
Case presentation
A man in the early 80s presented to the outpatient department with progressively worsening dysphagia to solids, resulting in a 10 kg weight loss over months. He also described a recent episode of breathing difficulty and a very brief expulsion of a solid mass from the mouth. To alleviate his respiratory symptoms, he used to reduce the mass manually.
Physical examination revealed that the oral cavity and oropharyngeal structures were normal. There was no cervical lymphadenopathy, and the neck was soft, with absent crepitus. Flexible endoscopy revealed a yellowish polypoidal lesion with multiple elongations in the hypopharynx that was likely to have originated from the posterior pharyngeal wall on the right side, across from the arytenoid cartilage. This lesion extended inferiorly into the lumen of the oesophagus without infiltration on the walls. The mass was encroaching on the posterior glottic region and blocking the airway. The larynx and oropharynx appeared normal, and the vocal cords were bilaterally mobile (figure 1). Upper gastrointestinal endoscopy revealed an intraoesophageal tumour that extended 30 cm from the dental arch.
Endoscopic view of a lipomatous tumour with attachment (black dot) prolapsing into the laryngeal lumen (yellow arrow).

Investigations
A barium contrast study revealed oesophageal dilatation in the proximal two-thirds, indicating an intraluminal tumour rather than extrinsic compression (figure 2).
Barium swallow showing the dilated oesophagus with intraluminal tumour (black arrow) in lateral neck view and (yellow arrow) in chest view.

Contrast-enhanced neck and chest CT revealed a 16 cmlong well-defined intramural round lesion with fat attenuation filling the oesophageal lumen, consistent with the diagnosis of benign lipoma lesions (figure 3).
CECT showing the well-defined intramural round lesion with fat attenuation filling the oesophageal lumen. CECT, Contrast-enhanced computed tomography.

Differential diagnosis
Based on the clinical appearance of an endoscopically evident fatty lesion and a thick stalk on the posterior pharyngeal wall with an elongated mass, we suspected benign FVP of the hypopharynx. Furthermore, the appearance of a lipomatous lesion on CT supports the diagnosis of FVP. Fibrolipomas, fibromyomas, hamartomas, fibromas and lipomas are other lesions that may look like FVP. We planned an endoscopic tumour excision because all these tumours are benign and require surgical excision to confirm the diagnosis.
Treatment
The polyp was sectioned at the base of its pedicle using a thunder beat vessel sealing device (OLYMPUS MEDICAL SYSTEM TB 5 mm, 35 cm) and the Wierda laryngoscope. Both the hypopharyngeal and oesophageal components were found pedunculated on a broad base that originated in the posterior pharyngeal wall areas of the hypopharynx. The tumour had the macroscopic appearance of a polyp with a smooth surface, measuring 16×5×4 cm, and consisted mainly of a 4 cm long pedicle (figure 4). After 72 hours of nasogastric tube feeding, the patient’s oral diet was restarted. There were no postoperative complications; thus, the patient was discharged. Contrary to our preoperative diagnosis, the histopathological examination demonstrated a well-differentiated liposarcoma with mature adipocytes and the tumour cells showing immunopositivity for S-100 and CD34.
Tumour specimen that was excised.

We advised him to have revision surgery to avoid recurrence after a tumour board discussion because we had previously performed surgery assuming he had a benign tumour. He has been informed about the disease’s nature and prognosis. Due to his age, surgical morbidities, the slow growth of the disease and the low likelihood of the disease spreading over a long distance, he and his family were hesitant to undergo revision surgery. They agreed to return regularly for active surveillance.
After reviewing the literature, we decided not to use any adjuvant therapy, such as radiation or chemotherapy.
Outcome and follow-up
On follow-up till 2 months, he had normal swallowing and breathing. We planned for an upper gastrointestinal endoscopy and an MRI 6-month postsurgery. Unfortunately, he succumbed to COVID-19 infection. His relatives consented to publication over the phone, which was documented. The anonymity of the patient is retained in this article.
Discussion
The clinical symptoms in our case were almost identical to those of a benign FVP, and CT scan findings contributed to this. The average tumour length reported in the literature is 7.60 cm. Only a few cases more extensive than 15 cm have been reported, and ours is one of them. Sudden death occurred in a few cases due to asphyxia and laryngeal obstruction caused by polyp regurgitation, the most feared complication of this polyp. As a result, conservative management is not recommended for this polyp.4–7 Endoscopy and radiological imaging were ineffective in distinguishing the malignant from the benign lesion and determining the lesion’s attachment. A preoperative biopsy or an intraoperative frozen section can rule out malignancy and confirm the disease pathology.
Wide excision of the lesion is the standard gold treatment for well-differentiated liposarcoma. The main challenge arises from the lack of exposure and proximity of nearby neurovascular structures. Two surgical approaches have been discussed in the literature: transcervical and transoral. To adequately excise the tumour, many surgeons preferred the transcervical route. The transoral approach is becoming increasingly popular because it enables appropriate tumour exposure via enhanced endoscopic technologies and vessel sealing devices for bleeding control. The difficulty in evaluating margins causes controversy, so an experienced surgeon is required for the transoral route. Clear margins are necessary to reduce the risk of recurrence, but they are not always possible due to anatomical limitations. Despite the theoretical possibility of low nodal metastasis, no case of lymph node metastasis has been reported in the studies, suggesting that addressing the neck nodes may not be necessary.6 8
Most of the time, it is assumed to be a benign lesion, and surgery, as in our case, is performed to treat it. In TNM (tumor node metastases) stage, ‘T’ stands for extend of the tumour, which is mainly indicates the deeper and surrounding penetration of the tumour rather than the proliferative component. Since it is a slow growing lesion the incidence of distant metastasis is very low. Even though the limited number of cases reported in the literature, the Lung is the most common site for metastasis, followed by liver. We had already done a CECT (contrast-enhanced computed tomography) Chest and thorax, which did not show any regional or distant metastasis. (3,6) Our case was classified as a T2N0M0 lesion (tumour >2 cm to ≤4 cm) by the American Joint Committee on Cancer’s eighth edition (2017) for soft tissue sarcoma of the head and neck. Because we performed an excision at the stalk’s base, we felt the margins needed to be revised. As a result, we decided to perform a revision surgery with a wider margin around the lesion. The tumour’s location and previous surgery may be challenging to assess the margin via the transoral route. Although the transcervical route is preferred for better results, its surgical morbidities are concerning.
The recurrence rate ranges from 30% to 80%, depending on the tumour grade and margin status. The recurrence of the lesion may behave similarly to the primary, but dedifferentiation is possible.2 Head and neck liposarcoma have a better prognosis than the rest of the body because it is diagnosed at an early stage (less than 5 cm), and most tumour grades are well differentiated. Despite recurrence, the 5-year overall survival rate is nearly 100%.1 6 After considering these factors, we discussed the next steps with the patient and his family. They have opted for monitoring as the prognosis is good. Radiological imaging and endoscopic evaluation should be performed after 6 months for tumour surveillance.
In the event of a recurrence, revision excision may be performed if feasible. Adjuvant therapy, such as radiation therapy (RT) or chemotherapy, has a hazy role. RT should not be used routinely in all cases except highly selected cases. Interval imaging can be used to monitor asymptomatic recurrence patients. Debulking surgery can help, even if it cannot altogether remove the tumour. Chemotherapy plays a limited role in treating symptomatic recurrence and metastatic disease. Trabectedin and eribulin for metastatic liposarcoma and CDK4 INHIBITORs for CDK4 amplified liposarcoma have been proposed as targeted therapies for such patients.6 9 10
Patient’s perspective
My father’s hospital stay was pleasant, and the surgery went well. He was doing well after the surgery. He would have stayed with us for a more extended period. Unfortunately, He passed away as a result of the COVID-19 infection. We thank the doctors and other healthcare providers caring for my father.
Learning points
-
Large pharyngoesophageal polyps can cause fatal airway obstruction.
-
Pharyngoesophageal liposarcoma has a similar clinical and radiological presentation to benign pharyngoesophageal polyps.
-
Consider a preoperative biopsy for proper management of such pharyngoesophageal mass.
-
Minimally invasive surgery is an option for its treatment.
-
Adjuvant therapy has a limited role.
Ethics statements
Patient consent for publication
Footnotes
-
Contributors The authors confirm contribution to the paper as follows: study conception and design: SM. Data collection: SA. GG: analysis and interpretation of results: SM, ASC, SA: draft manuscript preparation: GG, SA, SM. All authors reviewed the results and approved the final version of the manuscript.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer